TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CSTL

Castle Biosciences Inc

Healthcare · Diagnostics & Research

35.80$ +1.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CSTL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +65.7% +127.6% +20.8% +50.2% +45.7% +60.4% +51.1% +3.7%
– +7.6% +38.0% +32.5% +63.4% +102.3% +40.5% +33.8% +18.0%
– +98.0% +154.8% +18.9% +47.8% +34.2% +66.4% +55.5% +0.5%
– +8.5% +52.1% +79.5% +123.6% +51.5% +19.4% -2.9% -0.4%
– +7.9% +81.2% +61.3% +80.2% -35.0% +17.9% +15.2% +19.1%
– +8.1% +74.6% +59.8% +98.9% +50.3% +36.5% +8.4% +20.1%
– – – -189.3% – – – – -593.8%
– +37.8% +101.0% -42.4% -100.0% +1,600.0% -35.3% +5,145.5% -85.1%
– – – -290.7% – – – – -236.9%
– -11.6% +736.6% +16.7% -10,481.0% – – +3,186.1% -261.4%
– – – -294.9% – – – – -232.4%
– – – -169.0% – – – – -70.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?